Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
4
×
boston blog main
boston top stories
national blog main
national top stories
new york blog main
san francisco blog main
biotech
crispr
fda
new york top stories
roche
san francisco top stories
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
amgen
andrew oxtoby
babies
biology
biotechnology
boston
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
california
cambridge
cancer
cancer immunotherapy
center for medicare and medicaid services
ceo
cholesterol
clinical hold
clinical study
clinical trials
combination
commissioner
companion diagnostic
What
big
4
×
medicine
4
×
ceo
week
aces
acquire
agreed
agriculture
announced
billion
bio
biology
bosley's
bosley’s
bridge
broad
bucks
cas
cholesterol
claims
commercialize
confidence
crime
crispr
departure
didn’t
dna
drug
editas
equally
exit
faster
financing
flexible
forward
foundation
gain
genentech
genetic
guiding
Language
unset
Current search:
big
×
medicine
×
" life sciences "
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@techcrunch.com
5 years ago
DNA Script picks up $38.5 million to make DNA production faster and simpler
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine